Marker Therapeutics, Inc. (MRKR)

2.10 +0.06 (+2.94%) USD  |  NASDAQ  |  Jan 23, 16:00
2.09 -0.01 (-0.48%) After-Hours: 20:00
More

Marker Therapeutics Treasury Stock (5 Year Growth)

Treasury Stock (5 Year Growth) Chart

View Treasury Stock (5 Year Growth) for MRKR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Treasury Stock (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Treasury Stock (5 Year Growth) Range, Past 5 Years

View Treasury Stock (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Treasury Stock (5 Year Growth) Benchmarks

View Treasury Stock (5 Year Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. --
Viridian Therapeutics, Inc. --
Kiniksa Pharmaceuticals International Plc --
Neurocrine Biosciences, Inc. --
AIM ImmunoTech, Inc. --